Key result
In a randomized trial with technical credentialing, high surgeon volume did not predict differences in rates of conversion, complications, 5-year survival, or disease-free survival.
Why the study?
Does surgeon volume predict outcomes in colon cancer surgery when surgeons are technically credentialed?
RCT (n=871)
Yes
Does surgeon volume predict outcomes in colon cancer surgery when surgeons are technically credentialed?
In the setting of case-specific technical credentialing, surgeon volume does not predict differences in short- or long-term outcomes for colon cancer surgery.
Answers are grounded in this paper and cite their sources.
Credentialing may equalize colon cancer surgery outcomes across volumes; leaves open effects in non-credentialed settings.
In Brief Objective: To test the hypothesis that surgeon volume would not predict short- and long-term outcomes when evaluated in the setting of technical credentialing. Summary Background Data: Surgical volume is a known predictor of outcomes; the importance of technical credentialing has not been evaluated. Methods: Fifty-three credentialed surgeons operated on 871 patients in the Clinical Outcomes of Surgical Therapy Study (NCT00002575), investigating laparoscopic versus open surgery for colon cancer. Credentialing required that each surgeon document performance of at least 20 laparoscopic colon cases and demonstrate oncologic techniques on a video-recorded case. Surgeons were separated based on volume entered into the trial (low, ≤5 cases (n = 39); medium, 6–10 cases (n = 9); or high, >10 cases (n = 5)) and compared by outcomes. Results: Patients treated by high volume compared with medium or low volume surgeons were older (70, 66, and 68 years; P < 0.001), more often had right-sided tumors (63%, 46%, and 53%; P < 0.001) and had more previous operations (48%, 38% and 45%; P < 0.004), respectively. Mean operative times were shorter (123, 147 and 145 minutes; P < 0.001), distal margins longer (13.4, 12.4 and 11.6 cm; P = 0.005), and lymph node harvest greater (14.8, 12.8, 12.6; P = 0.05) for high versus medium versus low volume surgeons. However, rates of conversion, complications, 5-year survival, and disease-free survival showed no significant differences. Conclusion: When tested in a randomized controlled trial with case-specific surgical technical credentialing and auditing, surgeon volume did not predict differences in rates of conversion, complications, or long-term cancer outcomes. Case-specific technical credentialing should be further studied specific to the role it could play in creating consistent, high quality outcomes. We hypothesized that surgeon volume would not predict outcomes in a randomized trial with credentialing. From the Clinical Outcomes of Surgical Therapy study, 871 patients were separated into groups based on surgeon volume. This did not predict differences in conversion, complications, or cancer outcomes. The relationship between credentialing and quality outcomes should be further considered.
No takes yet. Share an insight, caveat, or question.
Larson et al. (2008) conducted an RCT in Colon cancer (n=871). High surgeon volume (>10 cases) vs. Medium (6-10 cases) or low (≤5 cases) surgeon volume was evaluated on Rates of conversion, complications, 5-year survival, and disease-free survival. In a randomized trial with technical credentialing, high surgeon volume did not predict differences in rates of conversion, complications, 5-year survival, or disease-free survival.
Synapse has enriched 10 related papers. Consider them for comparative context: